Document is current
Any future updates will be listed below
-
Authors
Gupta, Yakhlesh
Goswami, Sanjeev
Arora, Manvi
Malik, Nargis
Irshad, Khushboo
Kundu, Archismita
Gowda, Srinivas H.
Kapoor, Mani
Gupta, Shruti
Nag, Tapas Chandra
Suri, Vaishali
Suri, Ashish
Chattopadhyay, Parthaprasad
Sinha, Subrata
Chosdol, Kunzang https://orcid.org/0000-0002-7065-3395
-
Funding
Funding for this research was provided by:
Department of Biotechnology, Ministry of Science and Technology, India (BT/PR13357/MED/30/15322015, BT/GET/119/SP31652/2020)
Indian Council of Medical Research (R.12014/47/2022-HR, 52/12/2020-BIO/BMS)
- License Information
-
More Information
Article History
Received: 29 January 2025
Accepted: 4 August 2025
First Online: 3 September 2025
Declarations
:
: For glioblastoma patients’ tumor samples, work was done after taking due ethical clearance has been taken from the Institute Ethics Committee for Postgraduate (IECPG), AIIMS, New Delhi dated 5 March 2019 (file no. IECPG-111/28.02.2019). Animal experiments were approved by the Institutional Animal Ethics Committee (IAEC), AIIMS, New Delhi, 7 Feb 2017 (file no.974/IAEC/16) and Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) at Dabur Research Foundation, Ghaziabad (proposal no. IAEC/55/1015). The Local Ethics Committees comply with the rule and regulations of the International Council for Laboratory Animal Science (ICLAS). Cloning and recombinant DNA related work was done after obtaining due ethical clearance from the Institutional Committee on Biosafety for Recombinant DNA Research (file no. IBSC-16/8/16), AIIMS, New Delhi.
: Not applicable.
: The authors declare that they have no competing interests.
